
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.740 | 3.770 | 0.030 |
Shares | 96.260 | 96.260 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.745 | 17.149 |
Price to Book | 3.838 | 3.717 |
Price to Sales | 4.047 | 5.028 |
Price to Cash Flow | 12.743 | 14.632 |
Dividend Yield | 1.377 | 0.520 |
5 Years Earnings Growth | 25.340 | 8.646 |
Number of long holdings: 18
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 9.08 | 112.29 | -2.15% | |
VanEck Biotech ETF | - | 9.07 | - | - | |
First Trust NYSE Arca Biotech | US33733E2037 | 9.07 | 164.26 | -0.92% | |
iShares Nasdaq Biotechnology | US4642875565 | 8.81 | 132.76 | -0.70% | |
SPDR S&P Biotech | US78464A8707 | 8.74 | 85.66 | -0.67% | |
Amgen | US0311621009 | 8.62 | 295.10 | -2.08% | |
ALPS Medical Breakthroughs | US00162Q5936 | 8.62 | 32.65 | -0.94% | |
Bristol-Myers Squibb | US1101221083 | 7.03 | 43.31 | -5.81% | |
Regeneron Pharma | US75886F1075 | 6.76 | 545.46 | -1.64% | |
Merck&Co | US58933Y1055 | 6.53 | 78.12 | -4.44% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IBI Up to 3 Yrs 80 20 | 848.25M | 5.98 | 7.55 | 4.42 | ||
IBI 70 30 | 733.85M | 9.77 | 9.43 | - | ||
I.B.I. NASDAQ 100 Basket | 717.14M | -0.19 | 23.32 | 16.49 | ||
IBI 85 15 | 389.37M | 6.01 | 6.30 | 3.71 | ||
I.B.I Forex Hedged USA Basket | 331.74M | 2.44 | 14.48 | 10.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review